Standard Biotools Inc - Asset Resilience Ratio

Latest as of March 2026: 29.64%

Standard Biotools Inc (LAB) has an Asset Resilience Ratio of 29.64% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check LAB strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

$189.40 Million

Cash + Short-term Investments

Total Assets

$639.11 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2025)

This chart shows how Standard Biotools Inc's Asset Resilience Ratio has changed over time. See LAB net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Standard Biotools Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Standard Biotools Inc worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$189.40 Million	29.64%
Total Liquid Assets	$189.40 Million	29.64%

Asset Resilience Insights

Very High Liquidity: Standard Biotools Inc maintains exceptional liquid asset reserves at 29.64% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Standard Biotools Inc Industry Peers by Asset Resilience Ratio

Compare Standard Biotools Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
Shenzhen New Industries Biomedical SHE:300832	Medical Devices	9.95%
Jafron Biomedical Co Ltd SHE:300529	Medical Devices	39.15%
HOB Biotech Group Corp Ltd SHG:688656	Medical Devices	2.62%
Polynovo Ltd AU:PNV	Medical Devices	0.04%
Shanghai ZJ Bio-Tech Co. Ltd. A SHG:688317	Medical Devices	10.88%
Dirui Industrial Co Ltd SHE:300396	Medical Devices	6.89%
Emvision Medical Devices Ltd AU:EMV	Medical Devices	0.06%

Annual Asset Resilience Ratio for Standard Biotools Inc (2006–2025)

The table below shows the annual Asset Resilience Ratio data for Standard Biotools Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	12.22%	$69.36 Million	$567.75 Million	-8.38pp
2024-12-31	20.60%	$126.15 Million	$612.34 Million	+1.04pp
2023-12-31	19.56%	$63.19 Million	$323.07 Million	-22.92pp
2022-12-31	42.47%	$165.78 Million	$390.31 Million	+32.14pp
2021-12-31	10.34%	$28.45 Million	$275.21 Million	+3.96pp
2020-12-31	6.37%	$20.70 Million	$324.76 Million	-9.50pp
2019-12-31	15.87%	$42.02 Million	$264.81 Million	-9.72pp
2018-12-31	25.59%	$77.72 Million	$303.65 Million	+10.63pp
2017-12-31	14.97%	$43.01 Million	$287.35 Million	+0.13pp
2016-12-31	14.83%	$45.45 Million	$306.39 Million	-2.92pp
2015-12-31	17.75%	$65.86 Million	$371.06 Million	-2.27pp
2014-12-31	20.02%	$81.59 Million	$407.56 Million	-21.96pp
2013-12-31	41.98%	$49.08 Million	$116.92 Million	+23.20pp
2012-12-31	18.78%	$21.36 Million	$113.73 Million	-31.53pp
2011-12-31	50.32%	$39.91 Million	$79.33 Million	+38.84pp
2007-12-31	11.48%	$6.29 Million	$54.78 Million	+10.11pp
2006-12-31	1.37%	$500.00K	$36.49 Million	--

pp = percentage points

About Standard Biotools Inc

NASDAQ:LAB USA Medical Devices

Market Cap

$316.24 Million

Market Cap Rank

#14660 Global

#3423 in USA

Share Price

$0.81

Change (1 day)

-2.60%

52-Week Range

$0.80 - $1.68

All Time High

$14.36